In fiscal 2025, which ended Dec 31, 2025, Mettler-Toledo International Inc. reported revenue of $4.0 billion, up 4.0% from the year before. Net income was $869.2 million, a profit margin of 21.6%. Diluted earnings per share were $42.05. Across the 10 fiscal years shown, revenue grew from $2.3 billion in fiscal 2011 to $4.0 billion in fiscal 2025, about 6.4% a year.
USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.
| Line |
FY 2026
Mar 31, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2013
Dec 31, 2013
|
FY 2012
Dec 31, 2012
|
FY 2011
Dec 31, 2011
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
|
4,026
+4.0%
|
3,872
+2.2%
|
3,788
-3.4%
|
3,920
+5.4%
|
3,718
+20.5%
|
3,085
+2.5%
|
3,009
|
2,379
+1.6%
|
2,342
+1.4%
|
2,309
+17.3%
|
| Cost of revenue |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
795
-2.0%
|
811
+1.6%
|
799
+20.6%
|
| Gross profit |
—
|
2,391
+2.8%
|
2,326
+3.8%
|
2,241
-2.9%
|
2,308
+6.3%
|
2,172
+20.6%
|
1,801
+3.4%
|
1,741
|
1,282
+3.3%
|
1,241
+1.9%
|
1,218
+17.5%
|
| Research and development |
—
|
199
+5.3%
|
189
+2.2%
|
185
+4.6%
|
177
+4.3%
|
170
+21.2%
|
140
-2.7%
|
144
|
116
+3.4%
|
113
-3.1%
|
116
+19.7%
|
| Selling, general and administrative |
—
|
998
+6.6%
|
936
+3.6%
|
904
-3.7%
|
938
-0.6%
|
944
+15.1%
|
820
+0.1%
|
819
|
693
+1.3%
|
684
-2.8%
|
704
+19.5%
|
| Restructuring and impairment |
—
|
18
-9.6%
|
20
-39.6%
|
33
+242.6%
|
10
+82.4%
|
5
-50.2%
|
11
-33.3%
|
16
|
20
+18.8%
|
17
+182.3%
|
6
+21.5%
|
| Pretax income |
—
|
1,049
+1.1%
|
1,037
+6.5%
|
974
-9.0%
|
1,071
+12.8%
|
949
+26.8%
|
749
+9.9%
|
681
|
403
+5.3%
|
383
+9.6%
|
349
+13.5%
|
| Income tax |
—
|
180
+3.2%
|
174
-5.9%
|
185
-6.6%
|
198
+9.8%
|
180
+23.5%
|
146
+21.4%
|
120
|
97
+5.3%
|
92
+15.1%
|
80
+5.7%
|
| Net income |
—
|
869
+0.7%
|
863
+9.4%
|
789
-9.6%
|
873
+13.5%
|
769
+27.6%
|
603
+7.4%
|
561
|
306
+5.2%
|
291
+7.9%
|
269
+16.1%
|
| Basic EPS |
—
|
42.17
+3.7%
|
40.67
+12.7%
|
36.10
-6.9%
|
38.79
+16.7%
|
33.25
+31.7%
|
25.24
+10.5%
|
22.84
|
10.22
+9.1%
|
9.37
+10.9%
|
8.45
+21.1%
|
| Diluted EPS |
—
|
42.05
+3.9%
|
40.48
+12.8%
|
35.90
-6.5%
|
38.41
+17.2%
|
32.78
+31.6%
|
24.91
+10.9%
|
22.47
|
9.96
+9.0%
|
9.14
+11.3%
|
8.21
+20.7%
|
| Weighted average shares, basic |
—
|
21
-2.9%
|
21
-2.9%
|
22
-2.9%
|
22
-2.8%
|
23
-3.2%
|
24
-2.8%
|
25
|
30
-3.5%
|
31
-2.7%
|
32
-4.2%
|
| Weighted average shares, diluted |
—
|
21
-3.0%
|
21
-3.0%
|
22
-3.3%
|
23
-3.2%
|
23
-3.1%
|
24
-3.1%
|
25
|
31
-3.4%
|
32
-3.1%
|
33
-3.8%
|
| Other measures | |||||||||||
| Depreciation and amortization |
—
|
51
+1.6%
|
50
+2.9%
|
49
+4.6%
|
47
+4.0%
|
45
+7.0%
|
42
+7.8%
|
39
|
35
+4.0%
|
33
+5.5%
|
32
+6.7%
|
| Margins | |||||||||||
| Gross margin |
—
|
59.37%
|
60.06%
|
59.16%
|
58.88%
|
58.41%
|
58.38%
|
57.87%
|
53.89%
|
53.00%
|
52.75%
|
| Pretax margin |
—
|
26.05%
|
26.79%
|
25.70%
|
27.31%
|
25.53%
|
24.27%
|
22.65%
|
16.93%
|
16.34%
|
15.12%
|
| Profit margin |
—
|
21.59%
|
22.29%
|
20.82%
|
22.26%
|
20.68%
|
19.54%
|
18.65%
|
12.87%
|
12.42%
|
11.67%
|
| Effective tax rate |
—
|
17.13%
|
16.78%
|
18.99%
|
18.50%
|
19.00%
|
19.50%
|
17.65%
|
23.99%
|
23.98%
|
22.82%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.
New to this? Read How to Read an Income Statement, With a Real Example.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- MTD (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Columbus, OH
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1037646
- Former names
- MT INVESTORS INC/ (until Feb 13, 1998); METTLER TOLEDO INTERNATIONAL INC (until Nov 17, 1997); MT INVESTORS INC (until Nov 10, 1997)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Source: SEC EDGAR filings. This is company-reported data, not investment advice.